Cargando…

The immune phenotypes and different immune escape mechanisms in colorectal cancer

The tumor microenvironment (TME) plays a crucial role in tumor progression and metastasis. However, the immune phenotypes of colorectal cancer (CRC) and the underlying immune escape mechanism have not been studied sufficiently. A total of 1802 and 619 CRC samples from the microarray and TCGA cohorts...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Yihao, Xu, Yuqiu, Chang, Jiang, Chang, Wenju, Lv, Yang, Zheng, Peng, Zhang, Zhiyuan, Li, Zhiqiang, Lin, Qi, Tang, Wentao, Zhu, Dexiang, Ji, Meiling, He, Guodong, Feng, Qingyang, Xu, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399611/
https://www.ncbi.nlm.nih.gov/pubmed/36032084
http://dx.doi.org/10.3389/fimmu.2022.968089
_version_ 1784772563427131392
author Mao, Yihao
Xu, Yuqiu
Chang, Jiang
Chang, Wenju
Lv, Yang
Zheng, Peng
Zhang, Zhiyuan
Li, Zhiqiang
Lin, Qi
Tang, Wentao
Zhu, Dexiang
Ji, Meiling
He, Guodong
Feng, Qingyang
Xu, Jianmin
author_facet Mao, Yihao
Xu, Yuqiu
Chang, Jiang
Chang, Wenju
Lv, Yang
Zheng, Peng
Zhang, Zhiyuan
Li, Zhiqiang
Lin, Qi
Tang, Wentao
Zhu, Dexiang
Ji, Meiling
He, Guodong
Feng, Qingyang
Xu, Jianmin
author_sort Mao, Yihao
collection PubMed
description The tumor microenvironment (TME) plays a crucial role in tumor progression and metastasis. However, the immune phenotypes of colorectal cancer (CRC) and the underlying immune escape mechanism have not been studied sufficiently. A total of 1802 and 619 CRC samples from the microarray and TCGA cohorts were enrolled, respectively. The ssGSEA algorithm and unsupervised clustering were used for TME cell infiltration speculation and immune phenotype recognition in the above cohorts. A total of 447 samples from Zhongshan Hospital were collected for validation. Immunohistochemistry was performed in this cohort to quantify TME cell infiltration. The single-cell RNA-seq (scRNA-seq) data of 252,940 cells from 60 CRC samples was analyzed for further mechanistic exploration. CRC samples can be classified into three distinct immune phenotypes. Subtype 1, the immune-active subtype, was characterized by high infiltration of activated adaptive immune cells. Subtype 2, the immune-desert subtype, featured high tumor purity and low infiltration of immune and stromal cells. Subtype 3, the stroma-rich subtype, had high infiltration of stromal cells. The stroma-rich subtype conferred a significantly worse prognosis. The three subtypes had different immune escape mechanisms. The immune-active subtype has the highest immune checkpoint expression level. In comparison, the immune-desert subtype had the lowest immunogenicity and defective antigen presentation. The stroma-rich subtype lacked activated immune cells. In conclusion, distinct immune phenotypes and immune escape mechanisms may provide inspiration and direction for further research on CRC immunotherapy.
format Online
Article
Text
id pubmed-9399611
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93996112022-08-25 The immune phenotypes and different immune escape mechanisms in colorectal cancer Mao, Yihao Xu, Yuqiu Chang, Jiang Chang, Wenju Lv, Yang Zheng, Peng Zhang, Zhiyuan Li, Zhiqiang Lin, Qi Tang, Wentao Zhu, Dexiang Ji, Meiling He, Guodong Feng, Qingyang Xu, Jianmin Front Immunol Immunology The tumor microenvironment (TME) plays a crucial role in tumor progression and metastasis. However, the immune phenotypes of colorectal cancer (CRC) and the underlying immune escape mechanism have not been studied sufficiently. A total of 1802 and 619 CRC samples from the microarray and TCGA cohorts were enrolled, respectively. The ssGSEA algorithm and unsupervised clustering were used for TME cell infiltration speculation and immune phenotype recognition in the above cohorts. A total of 447 samples from Zhongshan Hospital were collected for validation. Immunohistochemistry was performed in this cohort to quantify TME cell infiltration. The single-cell RNA-seq (scRNA-seq) data of 252,940 cells from 60 CRC samples was analyzed for further mechanistic exploration. CRC samples can be classified into three distinct immune phenotypes. Subtype 1, the immune-active subtype, was characterized by high infiltration of activated adaptive immune cells. Subtype 2, the immune-desert subtype, featured high tumor purity and low infiltration of immune and stromal cells. Subtype 3, the stroma-rich subtype, had high infiltration of stromal cells. The stroma-rich subtype conferred a significantly worse prognosis. The three subtypes had different immune escape mechanisms. The immune-active subtype has the highest immune checkpoint expression level. In comparison, the immune-desert subtype had the lowest immunogenicity and defective antigen presentation. The stroma-rich subtype lacked activated immune cells. In conclusion, distinct immune phenotypes and immune escape mechanisms may provide inspiration and direction for further research on CRC immunotherapy. Frontiers Media S.A. 2022-08-10 /pmc/articles/PMC9399611/ /pubmed/36032084 http://dx.doi.org/10.3389/fimmu.2022.968089 Text en Copyright © 2022 Mao, Xu, Chang, Chang, Lv, Zheng, Zhang, Li, Lin, Tang, Zhu, Ji, He, Feng and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Mao, Yihao
Xu, Yuqiu
Chang, Jiang
Chang, Wenju
Lv, Yang
Zheng, Peng
Zhang, Zhiyuan
Li, Zhiqiang
Lin, Qi
Tang, Wentao
Zhu, Dexiang
Ji, Meiling
He, Guodong
Feng, Qingyang
Xu, Jianmin
The immune phenotypes and different immune escape mechanisms in colorectal cancer
title The immune phenotypes and different immune escape mechanisms in colorectal cancer
title_full The immune phenotypes and different immune escape mechanisms in colorectal cancer
title_fullStr The immune phenotypes and different immune escape mechanisms in colorectal cancer
title_full_unstemmed The immune phenotypes and different immune escape mechanisms in colorectal cancer
title_short The immune phenotypes and different immune escape mechanisms in colorectal cancer
title_sort immune phenotypes and different immune escape mechanisms in colorectal cancer
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399611/
https://www.ncbi.nlm.nih.gov/pubmed/36032084
http://dx.doi.org/10.3389/fimmu.2022.968089
work_keys_str_mv AT maoyihao theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT xuyuqiu theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT changjiang theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT changwenju theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT lvyang theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT zhengpeng theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT zhangzhiyuan theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT lizhiqiang theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT linqi theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT tangwentao theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT zhudexiang theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT jimeiling theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT heguodong theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT fengqingyang theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT xujianmin theimmunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT maoyihao immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT xuyuqiu immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT changjiang immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT changwenju immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT lvyang immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT zhengpeng immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT zhangzhiyuan immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT lizhiqiang immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT linqi immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT tangwentao immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT zhudexiang immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT jimeiling immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT heguodong immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT fengqingyang immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer
AT xujianmin immunephenotypesanddifferentimmuneescapemechanismsincolorectalcancer